These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34154795)

  • 81. Photoangiolytic laser treatment of recurrent respiratory papillomatosis: a scaled assessment.
    Kuet ML; Pitman MJ
    J Voice; 2013 Jan; 27(1):124-8. PubMed ID: 23102824
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Patient reported voice outcome in recurrent respiratory papillomatosis.
    van Nieuwenhuizen AJ; Rinkel RN; de Bree R; Leemans CR; Verdonck-de Leeuw IM
    Laryngoscope; 2010 Jan; 120(1):188-92. PubMed ID: 19877192
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prevalence of diabetes mellitus and its impact on disease severity in adult recurrent respiratory papillomatosis.
    Lee CJ; Allen CT; Merati AL
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):603-7. PubMed ID: 23851281
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Efficacy of cidofovir in recurrent juvenile respiratory papillomatosis.
    Valera F; Maldonato L; Lima J; Küpper DS; Lacerda RN; Mamede R; Ricz H
    Braz J Otorhinolaryngol; 2010; 76(6):713-7. PubMed ID: 21180938
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Systemic bevacizumab for recurrent respiratory papillomatosis.
    Baday YI; Ongkasuwan J; Venkatramani R
    Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110352. PubMed ID: 32906078
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effect of high-dose vocal fold injection of cidofovir and bevacizumab in a porcine model.
    Ahmed MM; Connor MP; Palazzolo M; Thompson ME; Lospinoso J; O'Connor P; Howard NS; Maturo SC
    Laryngoscope; 2017 Mar; 127(3):671-675. PubMed ID: 27452286
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis.
    Graupp M; Gugatschka M; Kiesler K; Reckenzaun E; Hammer G; Friedrich G
    Eur Arch Otorhinolaryngol; 2013 Feb; 270(2):641-6. PubMed ID: 23070260
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Smoking and Carcinoma Trends in Recurrent Respiratory Papillomatosis Patients.
    Freeman T; Erickson E; Koch B; Young T; Allen D; Kim B; deSilva B; Matrka L
    Ann Otol Rhinol Laryngol; 2023 Nov; 132(11):1380-1385. PubMed ID: 36879422
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis.
    Co J; Woo P
    Ann Otol Rhinol Laryngol; 2004 Nov; 113(11):859-62. PubMed ID: 15562893
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Systemic bevacizumab for pediatric patients with aggressive recurrent respiratory papillomatosis: One single-center experience of eight patients.
    Liu Z; Xiao Y; Xu J; Liu M; Han M; Hu W; Zhu D
    Laryngoscope Investig Otolaryngol; 2023 Apr; 8(2):435-440. PubMed ID: 37090874
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].
    Snoeck R; Wellens W; Desloovere C; Van Ranst M; Naesens L; De Clercq E; Feenstra L
    J Med Virol; 1998 Mar; 54(3):219-25. PubMed ID: 9515772
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Spontaneous Regression of Recurrent Respiratory Papillomatosis with HPV Vaccination: A Case Study.
    Nyirjesy S; Osmundson P; Matrka L
    J Voice; 2022 Jul; 36(4):587.e21-587.e25. PubMed ID: 32891477
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Bevacizumab as adjuvant therapy for recurrent respiratory papillomatosis in an infant.
    Gates C; Tomboc P; Allison A; Carr M
    Int J Pediatr Otorhinolaryngol; 2020 Feb; 129():109762. PubMed ID: 31707187
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Airway Papillomatosis: New Treatments for an Old Challenge.
    Kumar N; Preciado D
    Front Pediatr; 2019; 7():383. PubMed ID: 31620412
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Aggressive recurrent respiratory papillomatosis: A series of five consecutive patients successfully treated with adjuvant intravenous bevacizumab. A single Belgian academic center experience.
    Collette F; Lawson G; Hassid S; Delahaut G; Bachy V; Van Der Vorst S; Faugeras L; Gilliaux Q; D'Hondt L
    Head Neck; 2023 May; 45(5):1071-1079. PubMed ID: 36840929
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Scoping Review from 2009 to 2022.
    Torres-Canchala L; Cleves-Luna D; Arias-Valderrama O; Candelo E; Guerra MA; Pachajoa H; Olaya M
    Children (Basel); 2022 Dec; 10(1):. PubMed ID: 36670605
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cidofovir: to use or not to use?
    Soma MA; Albert DM
    Curr Opin Otolaryngol Head Neck Surg; 2008 Feb; 16(1):86-90. PubMed ID: 18197029
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.
    Intakorn P; Sonsuwan N
    J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S136-41. PubMed ID: 25391185
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Degrees of dysplasia based on viral typing in patients with cidofovir use and recurrent respiratory papillomatosis.
    Moore JE; Garcia A; Sanyal S; Saunders S; Portnoy JE; Hu A; Sataloff RT
    J Voice; 2013 Nov; 27(6):765-8. PubMed ID: 24128893
    [TBL] [Abstract][Full Text] [Related]  

  • 100. HPV genotype is a prognosticator for recurrence of respiratory papillomatosis in children.
    Nogueira RL; Küpper DS; do Bonfim CM; Aragon DC; Damico TA; Miura CS; Passos IM; Nogueira ML; Rahal P; Valera FCP
    Clin Otolaryngol; 2021 Jan; 46(1):181-188. PubMed ID: 32869523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.